Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
OBJECTIVES: There are few data on the cost-effectiveness of bisphosphonates with oral glucocorticoids (GCs). An individual patient-based pharmaco-economic model was developed. METHODS: Data were obtained from a cohort of oral GC users aged 40+ (n = 190 000) in the UK General Practice Research Databa...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|